Cited by CrossRef (2)

Abdülkadir Erçalışkan, Duygu Seyhan Erdoğan, Ahmet Emre Eşkazan. Current evidence on the efficacy and safety of generic imatinib in CML and the impact of generics on health care costs. 2021;5:3344
Ahmet Emre Eşkazan, Rıdvan Ali, Ebru Alnıgeniş, Orhan Ayyıldız, İbrahim Haznedaroğlu, Onur Kırkızlar, Erdal Kurtoğlu, Simten Malhan, Ergün Öksüz, Özlem Polat, Güray Saydam, Mehmet Sönmez, Selami Koçak Toprak, Tayfur Toptaş, Mehmet Turgut. Patient characteristics and management practices in chronic myeloid leukemia in Turkey: reflections from an expert meeting. Expert Review of Hematology 2022;15:97